| Element | Current quarter | Similar quarter for previous year | % Change current | Previous quarter | % Change previous |
|---|---|---|---|---|---|
| Net profit (loss) |
3,313,847
|
-
|
-
|
1,421,118
|
133.19
|
| Gross profit (loss) |
151,663,415
|
107,804,260
|
40.68
|
153,034,963
|
-
|
| Operational profit (loss) |
-
|
-
|
57.19
|
8,563,395
|
-
|
| All figures are in Saudi Arabia, Riyals | |||||
| Element | Current period | Similar period for previous year | % Change |
|---|---|---|---|
| Net profit (loss) |
45,069,544
|
6,712,843
|
571.39 |
| Gross profit (loss) |
660,968,184
|
585,754,389
|
12.84 |
| Operational profit (loss) |
13,242,198
|
2,686,752
|
392.87 |
| Earning or loss per share, Riyals |
0.56
|
0.08
|
- |
| All figures are in Saudi Arabia, Riyals | |||
| Element | EXPLAINATION |
|---|---|
| Reasons of increase (decrease) for quarter compared with same quarter last year | Net profit achieved in general due to:A. Increase in Gross Profit in Pharmaceuticals sector and decrease in gross losses in Power and Steel sectorWhile noting that it has partially offset by higher G&A in Holding Company and others sectorB. Decrease in other expenses mainly from lower currency exchange losses in the following sectors:a. Pharmaceuticals sector b. Specialty Chemicals sector |
| Reasons of increase (decrease) for period compared with same period last year | A. Increase in Gross Profit resulting from lower gross losses in Power and Steel sector and higher sales in the following sectors:a. Pharmaceuticals sector b. Specialty Chemicals sector While noting that General & Administration expenses and Selling and Marketing expenses are higher in all sectorsB. Decrease in other expenses mainly from currency exchange losses in the following sectors:a. Pharmaceuticals sector b. Specialty Chemicals sector |
| Reasons of increase (decrease) for quarter compared with previous quarter | Net profit increases in general due to:A. Decrease in other expenses mainly from lower currency exchange losses in the following sectors:a. Pharmaceuticals sector b. Specialty Chemicals sectorB. While noting that operating income is lower in the following sectors:a. Pharmaceuticals sectorb. Power and Steel sectorc. Holding Company and others sector |
| Reclassifications in quarterly financial results | Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. |
| Other notes | Comparatives figures for the similar twelve months period of the last year are from Audited Financial Statements.1. Revenue of the current quarter is SR 405,161,318/- compared to SR 422,920,256/- for the similar quarter last year, a decrease of 4.2%2. Revenue of the period is SR 1,753,804,312/- compared to SR 1,760,092,959/- for the similar period last year, a decrease of 0.4% 3. The shareholders equity (before minority interests) at the end of the period is SR 1,563,512,542/- compared to SR 1,716,690,277/- at the end of the similar period last year, a decrease of8.9% |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.